But over the years we've seen some drug companies do some curious things with this. We've actually seen them, I think, abuse this period of protection to create … The pharmaceutical company Abbvie used this strategy with their drug Humira, obtaining over 130 patents. … then they'll file additional patents that involve really minor and often unnecessary changes to their products. So they'll have a great pill and then they'll just change it to a capsule and then refile the patent. (02:34–02:41)
CLAIM
Asserts that Abbvie obtained over 130 patents for Humira to maintain market control.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
